By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson today said that it has received both US Food and Drug Administration clearance and a CLIA waiver for its new BD Veritor System for rapid detection of Flu A+B.

According to the company, BD Veritor is the first rapid influenza test system that incorporates a digital read out of results to receive CLIA waiver.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.